Lipoprotein cholesterol testing​ is a cornerstone of cardiovascular disease risk assessment, occupying a vital position in the global in-vitro diagnostics (IVD) market. With the escalating global burden of cardiovascular diseases and the proliferation of preventive healthcare, demand for lipoprotein cholesterol testing products is experiencing steady growth. The global cholesterol testing market was valued at USD 12.81 billion in 2024​ and is projected to reach USD 22.68 billion by 2032, growing at a CAGR of 8.5%. This comprehensive guide analyzes the global buyer landscape, covering hospitals, diagnostic laboratories, research institutions, and other key purchasers, and provides in-depth insights into market trends, regional procurement patterns, and supplier strategies. 1. Market Overview: Size,…